{"originalText": "，患者因卵巢癌于2016-04-12行“经腹筋膜外子宫+两附件切除+大网膜切除+阑尾切除+盆腔转移病灶清除+肿瘤细胞减灭术”，手术过程顺利，术后输液抗炎治疗。，常规病理结果示：（两侧附件）高级别浆液性乳头状癌，右卵巢肿物切面积2.8*1.5CM，左卵巢肿物切面积6*3.5CM，两侧输卵管查见癌。阑尾、“盆腔转移灶”查见癌，另送大网膜组织中查见癌。（子宫）萎缩的子宫内膜；慢性宫颈炎。右宫旁查见癌，左宫旁未查见癌。，免疫组化：ER(2+,20%),PR(1+,2%),WT-1(+),P53(-),KI67阳性率约50%。于2016-01-22给予多西他赛（多帕菲）100MG+卡铂400MG方案化疗，患者住院期间化疗毒副反应轻。今日入院，拟行第2次化疗。患者自出院后，无发热，无咳嗽咳痰，恶心呕吐轻，无腹痛腹胀，无阴道流血及排液，饮食睡眠可，大小便无异常，体重增加1KG。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 4, "end_pos": 7}, {"label_type": "手术", "overlap": 0, "start_pos": 20, "end_pos": 61}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 88, "end_pos": 104}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 186, "end_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 194}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 199, "end_pos": 201}, {"end_pos": 278, "label_type": "药物", "overlap": 0, "start_pos": 274}, {"end_pos": 282, "label_type": "药物", "overlap": 0, "start_pos": 279}, {"end_pos": 291, "label_type": "药物", "overlap": 0, "start_pos": 289}, {"end_pos": 353, "label_type": "解剖部位", "overlap": 0, "start_pos": 352}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}]}
